GAGert A. Van Assche
Gert A. Van Assche
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gert A. Van Assche has a total of 311 co-authors. Here are the top co-authors by number of shared publications:
- Severine Vermeire
Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
100 shared publications - Paul J. Rutgeerts
University Hospital Gasthuisberg, Leuven, Belgium
58 shared publications - Marc Ferrante
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
55 shared publications Vera Ballet
21 shared publicationsMaja Noman
19 shared publications- Ann Gils
Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium
18 shared publications
Latest Publications
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Su1823 - The Clinical Utility of a Multi-Marker Serum Test for Assessment of Ulcerations in Infliximab Treated Patients with Crohn's Disease
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Su1823 - The Clinical Utility of a Multi-Marker Serum Test for Assessment of Ulcerations in Infliximab Treated Patients with Crohn's Disease
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1846 - Adaptive Dosing During Infliximab Induction Therapy can Improve Mucosal Healing Rates in Patients with Ulcerative Colitis
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Mo1846 - Adaptive Dosing During Infliximab Induction Therapy can Improve Mucosal Healing Rates in Patients with Ulcerative Colitis
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1808 - Colonic Inflammation Determines Ileal Gene Expression Changes in Ulcerative Colitis
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Tu1808 - Colonic Inflammation Determines Ileal Gene Expression Changes in Ulcerative Colitis
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
906 - Efficacy and Safety of Upadacitinib Maintenance Treatment for Moderate to Severe Crohn's Disease: Results from the Celest Study
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
906 - Efficacy and Safety of Upadacitinib Maintenance Treatment for Moderate to Severe Crohn's Disease: Results from the Celest Study
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Su1834 - Serum Marker Panel for Detection of Mucosal Healing in Adalimumab Treated Patients with Ulcerative Colitis
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Su1834 - Serum Marker Panel for Detection of Mucosal Healing in Adalimumab Treated Patients with Ulcerative Colitis
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
600 - Endoscopy Based Therapeutic Management in Postoperative Recurrent Crohn's Disease: Results of a Multi-Center Retrospective Study
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
600 - Endoscopy Based Therapeutic Management in Postoperative Recurrent Crohn's Disease: Results of a Multi-Center Retrospective Study
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Sa1704 - Infliximab and Vedolizumab Show a Different Effect on Clot Formation in Inflammatory Bowel Disease Patients
- 1 May 2018
- Published by Elsevier in Gastroenterology
- Vol. 154 (6)
Sa1704 - Infliximab and Vedolizumab Show a Different Effect on Clot Formation in Inflammatory Bowel Disease Patients